Interactions between H. pylori infection, gastric acid secretion and anti-secretory therapy.
about
Helicobacter pylori Infection in Gastroesophageal Reflux Disease in the Asian CountriesRisk factors for failure of Helicobacter pylori therapy--results of an individual data analysis of 2751 patients.Helicobacter pylori-derived extracellular vesicles increased in the gastric juices of gastric adenocarcinoma patients and induced inflammation mainly via specific targeting of gastric epithelial cellsReview article: Helicobacter pylori and gastric cancer--the clinicians'point of view.Beyond the stomach: an updated view of Helicobacter pylori pathogenesis, diagnosis, and treatment.Review article: Helicobacter pylori and gastro-oesophageal reflux disease.Review article: Helicobacter pylori infection from pathogenesis to treatment--a critical reappraisal.Histamine 3 receptor activation mediates inhibition of acid secretion during Helicobacter-induced gastritis.Transient and persistent Helicobacter pylori colonization in Native American children.Helicobacter pylori in First Nations and recent immigrant populations in Canada.Helicobacter pylori virulence genes and host genetic polymorphisms as risk factors for peptic ulcer diseaseAssociation between Gastric pH and Helicobacter pylori Infection in Children.Gastroenterology in developing countries: issues and advances.Helicobacter pylori and gastroesophageal reflux disease: a case-control studyAntisecretory Action of the Extract of the Aerial Parts of Eremomastax speciosa (Acanthaceae) Occurs through Antihistaminic and Anticholinergic Pathways.Helicobacter pylori infection in functional dyspepsia.Medicinal plants in the treatment of Helicobacter pylori infections.The Gastric and Intestinal Microbiome: Role of Proton Pump Inhibitors.Should we still subcategorize helicobacter pylori-associated dyspepsia as functional disease?Seroprevalence of Helicobacter pylori infection in chagasic and nonchagasic patients from the same geographical region of Brazil.Histological and endoscopic features of the stomachs of patients with Chagas disease in the era of Helicobacter pylori.Double gastric infection with Helicobacter pylori and non-Helicobacter pylori bacteria during acid-suppressive therapy: increase of pro-inflammatory cytokines and development of atrophic gastritis.Wheat-dependent exercise-induced anaphylaxis following laparoscopic adjustable gastric banding procedure associated with Helicobacter pylori infection.Symptoms, endoscopic findings and histology predicting symptomatic benefit of Helicobacter pylori eradication.The effect of Helicobacter pylori eradication on gastro-oesophageal reflux.Randomised clinical trial: a novel rabeprazole extended release 50 mg formulation vs. esomeprazole 40 mg in healing of moderate-to-severe erosive oesophagitis - the results of two double-blind studies.Selective killing of Helicobacter pylori with pH-responsive helix-coil conformation transitionable antimicrobial polypeptides.Simultaneous assessment of gastric emptying and secretion in rats by a novel computed tomography-based method.Long-term follow up of Helicobacter pylori IgG serology after eradication and reinfection rate of H. pylori in South Korea.Serum ferritin, vitamin B(12), folate, and zinc levels in children infected with Helicobacter pylori.
P2860
Q28085263-2BB966BD-7ADB-43EF-A140-701DE2091589Q33185503-3CEB72ED-03F6-4E61-9236-5A8AE1C2AA24Q33754054-FF118414-F747-4092-9F16-33B5A1C962EAQ34069845-F763D44C-634E-4832-8BD7-30BFE6177A82Q34255425-0086AA7E-877B-4ECF-AC2E-EE11183EE969Q34436774-40F5C3F0-A428-47E6-8CEA-1C1824C13933Q34669294-84C88673-B017-46AB-8204-2CDD6383059FQ34992371-99D2ACEA-85AB-4BFD-811B-AC49CA9F4AACQ35028069-FD7AD426-CAA6-43BA-9A1D-0BEE12BF5E56Q35744635-D5442ED9-DD3F-474F-B018-27C9DD0EB5C6Q35809238-F9529B7E-62EF-4365-AC39-271422523BF8Q36461440-91FF4AD7-ED17-41A5-8D21-F8638154C243Q37233997-1BC7C9C2-CA08-46CE-A282-A742492D3C8BQ37270990-8327BED9-DAF6-42AD-8CE4-B9A017226C2CQ37631767-611285F5-20D9-4CAF-BFAA-C48747892D23Q38077448-1ECBC4C9-05E6-41B5-B68D-E07F0374D104Q38272171-59770313-F418-4F39-9A7D-231D9C229951Q38653409-320F4B5A-F7EB-4211-97E4-E66BC61C251FQ39543042-70DABF8B-70EC-4EF6-A8FD-51FB67A2545AQ40032509-B5EAE47F-E086-4909-8DAD-26A80024FD57Q41518934-696F493C-3D5B-4203-9D3D-7186310C8883Q43687355-332E95F6-A33A-42EF-A799-1C88CF0D1E82Q43944868-42B2DF29-7EAB-4FE7-9A8B-5DAD723BEA93Q44407907-EE8DBE9A-9E6A-41DA-8675-4589AFDC742DQ44978762-EE80C140-D9BF-4F9A-B3E6-8D141973EBAAQ46617274-09C3D218-447B-4C2D-AA59-D30A9DCD5265Q47352791-07C43FE1-1EED-457A-BA74-C533B2E176E8Q50483169-539A78B4-5BAF-4D69-89B5-C23236F658DDQ51120017-DE2389F4-9EC3-451B-9256-F5A19B750BEEQ51481464-46D5BE4A-E318-4483-9639-941B49517CA3
P2860
Interactions between H. pylori infection, gastric acid secretion and anti-secretory therapy.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Interactions between H. pylori ...... on and anti-secretory therapy.
@en
Interactions between H. pylori ...... on and anti-secretory therapy.
@nl
type
label
Interactions between H. pylori ...... on and anti-secretory therapy.
@en
Interactions between H. pylori ...... on and anti-secretory therapy.
@nl
prefLabel
Interactions between H. pylori ...... on and anti-secretory therapy.
@en
Interactions between H. pylori ...... on and anti-secretory therapy.
@nl
P2093
P1476
Interactions between H. pylori ...... on and anti-secretory therapy.
@en
P2093
P304
P356
10.1093/OXFORDJOURNALS.BMB.A011663
P577
1998-01-01T00:00:00Z